The Surgery of Mitral Stenosis 1898-1948: Why Did It Take 50 Years to Establish Mitral Valvotomy?

Total Page:16

File Type:pdf, Size:1020Kb

The Surgery of Mitral Stenosis 1898-1948: Why Did It Take 50 Years to Establish Mitral Valvotomy? Ann R Coll Surg Engl 1995; 77: 145-151 The surgery of mitral stenosis 1898-1948: why did it take 50 years to establish mitral valvotomy? Tom Treasure MD MS FRCS Consultant Cardiac and Thoracic Surgeon St George's Hospital, London Arthur Hollman MD FRCP FLS Emeritus Consulting Cardiologist University College Hospital, London, and Honorary Senior Lecturer Department of Medicine, University College London Medical School The first suggestion that surgery might relieve mitral she had a floppy valve and the diagnosis of rheumatic stenosis was in 1898 (1) and yet it was not until 1948, mitral disease was wrong. We have taken the heart out of fully 50 years later, that the operation of mitral valvotomy its pot and studied it. She had rheumatic disease and died became established (2-4). In 1925, Henry Souttar (Fig. 1) without restenosis. Souttar explained the rationale, operated on a 15-year-old girl with rheumatic mitral valve described the operation and performed it. What was it disease at the London Hospital (5). He had foresight, and that halted progress until after the Second World War, a clarity of thought, which makes him stand out among all and what happened then to permit progress to continue? the other pioneers whose writings we have studied. He First, we must appreciate that we are unlikely to find realised that: "the heart is as amenable to surgical the full story in the medical literature. Case reports, single treatment as any other organ". The valvular conse- or in series, are heavily biased in favour of reporting quences of rheumatic fever were common and he was achievement. Many ofthefailures that occur inthe course of familiar with the pathological appearance of mitral medical progress, pass unrecorded. Claims are made in stenosis and predicted that large print while retractions, if they are ever made, command less prominent coverage in the medical press, just the consecutive changes to which these lesions may have despite as in the popular press. Furthermore, the medical literature given rise in the cardiac muscle, the relief of the lesions reports facts in a way that enables us to identify landmarks, themselves would undoubtedly be of immense, service to the a at not patient and must be followed by marked improvement in his while tide ofopinion that is evident the time may be general condition (5). readily accessible and is lost to us. We can see what was written but we cannot guess what the contemporary reader His patient survived, left hospital at 2.5 weeks and went in the 1920s may have read between the lines. on to live an improved life, dying of cerebral embolism in There is plentiful literature in the late 1940s and early 1932 (6,7). 1950s, the renaissance of a surgical approach to mitral In retrospect, this report is recognised as a surgical stenosis, when Bailey (2), Harken et al. (3), Baker et al. landmark, but why did Souttar fail to repeat the (4) and others (8) added many successful surgical cases operation? Why did it take until 1948 for mitral to the literature. They were at last able to vindicate valvotomy to become routine practice? It has been said Souttar's opinion that "the problem is to a large extent that Souttar had operated on other patients with mitral mechanical, and as such should already be within the valve disease who died. If so, where is the evidence? It has scope of surgery". They demonstrated that structural been said that Lily Hine, his 19-year-old patient had abnormalities of the heart not only contributed to the predominant regurgitation, not mitral stenosis. An symptoms and morbidity of the patient, but were informed reading of the operation note confirms that amenable to anatomical correction. there was tight stenosis. It has even been suggested that There are two further interesting phases in the evolution of treatment of mitral stenosis. The first was the Correspondence to: Professor Tom Treasure, St George's refinement of the surgery of mitral stenosis by performing Hospital, Blackshaw Road, London SE17 OQT the operation on cardiopulmonary bypass, under direct 146 T Treasure and A Hollman obviously a puzzle and Samways writes: "a stenosed and incompetent valve may be present and regurgitation with its accompanying systolic murmur be absent, as is so frequently found". We now use the words incompetent and regurgitation interchangeably, but here there was obviously a different connotation. Later, there seems to have been an inherent assumption that stenosis could only be relieved at the expense of regurgitation. Brock appreciated that freeing the commissures did not necessarily induce regurgitation but might actually reduce existing valvular incompetence (16). Samways concludes his article: ... I anticipate that with the progress of cardiac surgery some of the severest cases of mitral stenosis will be relieved by slightly notching the mitral orifice and trusting the auricle to continue its defence. He had not seen the possibility of splitting the commissures and his notion that the atrium would ensure onward flow by a peristalsis-like action was an interesting if ingenious error. But his anticipation that cardiac surgery would be the solution to mitral stenosis was fully 50 years ahead of its time. Samways was not alone in his preoccupation with a mechanical solution to mitral stenosis. Sir Lauder Brunton's 'Preliminary note on treating mitral stenosis by surgical methods' appeared in 1902 (17). He was impressed by the widespread suffering caused by this Figure 1. Sir Henry Sessions Souttar (1875-1964) Henry disease and the completely ineffectual treatment available. Souttar took a double first in mathematics and also He saw the stenosed mitral valve as amenable to surgical studied engineering at Oxford. He was a clinical student treatment: at the London Hospital where he qualified in 1906. (Biographical details from Robinson RHOB, Le Fanu On looking at the contracted mitral orifice in a severe case of this WR. Lives of the Fellows of the Royal College of Surgeons of disease one is impressed by the hopelessness of ever finding a England 1952-1964. Edinburgh and London: E & S remedy which will enable the auricle to drive blood in a sufficient Livingstone, 1970.) stream through the small mitral orifice, and the wish unconsciously arises that one could divide the constriction as easily during life as one can after death. vision (9-11). Then a return to the closed approach for Brunton addressed two important technical questions. pure, uncomplicated mitral stenosis with a transatrial Namely, the choice of approach, atrial or ventricular, and balloon closely mimicking Souttar's approach (12). Could whether to split the valve along its commissures, or to cut there be a better vindication of all that Souttar believed the cusps at right-angles to the orifice. Both became major about the importance of the valve lesion and that it was issues in Souttar's time and were again debated in the largely amenable to a mechanical solution, best achieved postwar era. by reopening the commissural fusion? (13-15). Brunton's choice of ventricular incision did not eventually prove to be the best way, but he made the correct choice regarding the technique of relieving the The first ideas stenosis itself. The first question that arises is whether the mitral orifice should In 1898 Samways wrote a short paper entitled 'Cardiac be enlarged by elongating the natural opening or whether the peristalsis: its nature and effects' (1), pointing out that valves should be cut through their middle at right angles to the atrial contraction continues after ventricular contraction normal opening. I think there can be little doubt that the former has begun. He saw this as "peristaltic contraction in would be the better plan. sequence, with overlapping of the contractions of adjacent Samways appears in the correspondence column a segments". At first sight this seems obscure and later with a witty but, as it turns out, a in fortnight irrelevant, but Samways saw practical application inappropriate trivialisation of this critical surgical detail. that the contracting atrium may aid onward flow of blood even in the face of an incompetent mitral valve. This is The question which Sir Lauder Brunton raises whether to important in our attempts to understand some of the elongate the natural opening or cut the valves transversely is a arguments of the day. Valvular regurgitation was problem somewhat similar to 'which foot should be drawn down Surgery of mitral stenosis 147 in podalic version?' Probably in practice they may be congratulated who succeed with either (18). The nuances of bringing down the foot may be lost on many of us, but the alternatives in opening a stenosed mitral valve are not equivalent. The American surgeon, Cutler, knew Brunton's paper but chose to ignore this clearly expressed advice when he came to operate for mitral stenosis in 1923 (19). That was an important error which probably marred his results and may have been a major factor in halting progress towards mitral valvotomy. At the time, Brunton was not let off lightly. Arbuthnot Lane wrote to say that he had the idea "some years ago" and was prepared to go ahead and operate but was dissuaded by his physician colleague (20). Others were Figure 2. The heart from Souttar's patient is still even less receptive of Brunton's views. The Lancet preserved in the museum of the Royal London Hospital published an editorial comment the following week where we were fortunate to be allowed to examine it. (21). Brunton's opinions themselves, and his right to Professor M J Davies (British Heart Foundation express them at so early a stage in the evolution of his Professor of Cardiac Pathology) noted the evidence of ideas, were both roundly criticised; surely not by the very rheumatic heart disease.
Recommended publications
  • Closed Mitral Commissurotomy—A Cheap, Reproducible and Successful Way to Treat Mitral Stenosis
    149 Editorial Closed mitral commissurotomy—a cheap, reproducible and successful way to treat mitral stenosis Manuel J. Antunes Clinic of Cardiothoracic Surgery, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Correspondence to: Prof. Manuel J. Antunes. Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal. Email: [email protected]. Provenance and Peer Review: This article was commissioned by the Editorial Office, Journal of Thoracic Disease. The article did not undergo external peer review. Comment on: Xu A, Jin J, Li X, et al. Mitral valve restenosis after closed mitral commissurotomy: case discussion. J Thorac Dis 2019;11:3659-71. Submitted Oct 23, 2019. Accepted for publication Nov 29, 2019. doi: 10.21037/jtd.2019.12.118 View this article at: http://dx.doi.org/10.21037/jtd.2019.12.118 In the August issue of the Journal, Xu et al. (1), from Bayley (4,5) and then became widely accepted. Subsequently, China, discuss the case of a patient who had a successful the technique of CMC suffered several modifications, both reoperation for restenosis of the mitral valve performed in the way the mitral valve was accessed and split. Several 30 years after closed mitral commissurotomy (CMC). instruments were created to facilitate the opening of the The specific aspects of this case were most appropriately commissures, culminating with the development of the commented by several experienced surgeons from different Tubbs dilator, which became the standard instrument for parts of the world. I was now invited by the Editor of this the procedure (Figure 1). Journal to write a Comment on this paper and its subject.
    [Show full text]
  • View Pdf Copy of Original Document
    Phenotype definition for the Vanderbilt Genome-Electronic Records project Identifying genetics determinants of normal QRS duration (QRSd) Patient population: • Patients with DNA whose first electrocardiogram (ECG) is designated as “normal” and lacking an exclusion criteria. • For this study, case and control are drawn from the same population and analyzed via continuous trait analysis. The only difference will be the QRSd. Hypothetical timeline for a single patient: Notes: • The study ECG is the first normal ECG. • The “Mildly abnormal” ECG cannot be abnormal by presence of heart disease. It can have abnormal rate, be recorded in the presence of Na-channel blocking meds, etc. For instance, a HR >100 is OK but not a bundle branch block. • Y duration = from first entry in the electronic medical record (EMR) until one month following normal ECG • Z duration = most recent clinic visit or problem list (if present) to one week following the normal ECG. Labs values, though, must be +/- 48h from the ECG time Criteria to be included in the analysis: Criteria Source/Method “Normal” ECG must be: • QRSd between 65-120ms ECG calculations • ECG designed as “NORMAL” ECG classification • Heart Rate between 50-100 ECG calculations • ECG Impression must not contain Natural Language Processing (NLP) on evidence of heart disease concepts (see ECG impression. Will exclude all but list below) negated terms (e.g., exclude those with possible, probable, or asserted bundle branch blocks). Should also exclude normalization negations like “LBBB no longer present.”
    [Show full text]
  • Medicare National Coverage Determinations Manual, Part 1
    Medicare National Coverage Determinations Manual Chapter 1, Part 1 (Sections 10 – 80.12) Coverage Determinations Table of Contents (Rev. 10838, 06-08-21) Transmittals for Chapter 1, Part 1 Foreword - Purpose for National Coverage Determinations (NCD) Manual 10 - Anesthesia and Pain Management 10.1 - Use of Visual Tests Prior to and General Anesthesia During Cataract Surgery 10.2 - Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post- Operative Pain 10.3 - Inpatient Hospital Pain Rehabilitation Programs 10.4 - Outpatient Hospital Pain Rehabilitation Programs 10.5 - Autogenous Epidural Blood Graft 10.6 - Anesthesia in Cardiac Pacemaker Surgery 20 - Cardiovascular System 20.1 - Vertebral Artery Surgery 20.2 - Extracranial - Intracranial (EC-IC) Arterial Bypass Surgery 20.3 - Thoracic Duct Drainage (TDD) in Renal Transplants 20.4 – Implantable Cardioverter Defibrillators (ICDs) 20.5 - Extracorporeal Immunoadsorption (ECI) Using Protein A Columns 20.6 - Transmyocardial Revascularization (TMR) 20.7 - Percutaneous Transluminal Angioplasty (PTA) (Various Effective Dates Below) 20.8 - Cardiac Pacemakers (Various Effective Dates Below) 20.8.1 - Cardiac Pacemaker Evaluation Services 20.8.1.1 - Transtelephonic Monitoring of Cardiac Pacemakers 20.8.2 - Self-Contained Pacemaker Monitors 20.8.3 – Single Chamber and Dual Chamber Permanent Cardiac Pacemakers 20.8.4 Leadless Pacemakers 20.9 - Artificial Hearts And Related Devices – (Various Effective Dates Below) 20.9.1 - Ventricular Assist Devices (Various Effective Dates Below) 20.10 - Cardiac
    [Show full text]
  • Coders' Desk Reference for ICD-10-PCS Procedures
    2 0 2 DESK REFERENCE 1 ICD-10-PCS Procedures ICD-10-PCS for DeskCoders’ Reference Coders’ Desk Reference for ICD-10-PCS Procedures Clinical descriptions with answers to your toughest ICD-10-PCS coding questions Sample 2021 optum360coding.com Contents Illustrations ..................................................................................................................................... xi Introduction .....................................................................................................................................1 ICD-10-PCS Overview ...........................................................................................................................................................1 How to Use Coders’ Desk Reference for ICD-10-PCS Procedures ...................................................................................2 Format ......................................................................................................................................................................................3 ICD-10-PCS Official Guidelines for Coding and Reporting 2020 .........................................................7 Conventions ...........................................................................................................................................................................7 Medical and Surgical Section Guidelines (section 0) ....................................................................................................8 Obstetric Section Guidelines (section
    [Show full text]
  • Comparison of Isothermic and Cold Cardioplegia in Cardiac Surgery in Salem District
    Pon. A. Rajarajan. Comparison of isothermic and cold cardioplegia in cardiac surgery in Salem District. IAIM, 2019; 6(3): 266-271. Original Research Article Comparison of isothermic and cold cardioplegia in cardiac surgery in Salem District Pon. A. Rajarajan* Associate Professor. Department of Cardio-Thoracic Surgery, Government Mohan Kumaramangalam Medical College Hospital, Salem, Tamil Nadu, India *Corresponding author email: [email protected] International Archives of Integrated Medicine, Vol. 6, Issue 3, March, 2019. Copy right © 2019, IAIM, All Rights Reserved. Available online at http://iaimjournal.com/ ISSN: 2394-0026 (P) ISSN: 2394-0034 (O) Received on: 03-03-2019 Accepted on: 09-03-2019 Source of support: Nil Conflict of interest: None declared. How to cite this article: Pon. A. Rajarajan. Comparison of isothermic and cold cardioplegia in cardiac surgery in Salem District. IAIM, 2019; 6(3): 266-271. Abstract Background: Perioperative myocardial damage is one of the most common causes of morbidity and mortality after heart surgery. The improvement of the technique of myocardial preservation has contributed greatly to significant advances in cardiac surgery. However, serious questions remain regarding the use of warm versus cold cardioplegia, blood versus crystalloid cardioplegia, antegrade versus retrograde delivery and intermittent versus continuous perfusion. Cardioplegic solution is the means by which the ischemic myocardium is protected from cell death. This is achieved by reducing myocardial metabolism through a reduction in cardiac workload and by the use of hypothermia. Chemically, the high potassium concentration present in most cardioplegic solutions decreases the membrane resting potential of cardiac cells. The normal resting potential of ventricular myocytes is about -90 mV.
    [Show full text]
  • ICD-9-CM Procedures (FY10)
    2 PREFACE This sixth edition of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is being published by the United States Government in recognition of its responsibility to promulgate this classification throughout the United States for morbidity coding. The International Classification of Diseases, 9th Revision, published by the World Health Organization (WHO) is the foundation of the ICD-9-CM and continues to be the classification employed in cause-of-death coding in the United States. The ICD-9-CM is completely comparable with the ICD-9. The WHO Collaborating Center for Classification of Diseases in North America serves as liaison between the international obligations for comparable classifications and the national health data needs of the United States. The ICD-9-CM is recommended for use in all clinical settings but is required for reporting diagnoses and diseases to all U.S. Public Health Service and the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration) programs. Guidance in the use of this classification can be found in the section "Guidance in the Use of ICD-9-CM." ICD-9-CM extensions, interpretations, modifications, addenda, or errata other than those approved by the U.S. Public Health Service and the Centers for Medicare & Medicaid Services are not to be considered official and should not be utilized. Continuous maintenance of the ICD-9- CM is the responsibility of the Federal Government. However, because the ICD-9-CM represents the best in contemporary thinking of clinicians, nosologists, epidemiologists, and statisticians from both public and private sectors, no future modifications will be considered without extensive advice from the appropriate representatives of all major users.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Cardiac Surgery
    Minimally Invasive Port-Access Cardiac Surgery Lawrence M Prescott, phlp OVLRVlEW OF CARDIAC SURGERY tions, pain and suffering, convalescence and cost, while main- Since heart surgery was pioneered in the mid-1950s. remark- taining the high efficacy of conventional open-chest surgery. able advances have occurred in the surgical treatment of car- One of these approaches, percutaneous transluminal coro- diovascular disease. Coronary artery bypass graft (CAW) pro- nary angioplasty (PTCA) or balloon angioplasty was devel- cedures are the most effective treatment for coronary artery oped as an altemative to coronary artery bypass graft (CABG) disease. This treatment utilizes an artery or vein to bypass the surgery. While less invasive than conventional CAW, a narrowing in a coronary artery and restore blood flow down- major drawback of PTCA is the high frequency of restenosis, stream of the narrowing. For valvular heart disease (VHD), which occurs at rates ranging from 25 percent to 50 percent. the treatment involves either repairing the diseased heart Ultimately, the majority of angioplasty patients undergo valve, most commonly with the implantation of a prosthetic another PTCA procedure or CABG surgery. annul~plastyring, or replacing it with a prosthetic mechanical Another less-invasive altemative to cokentional open-chest or tissue valve. CABG surgery was developed by a $mall number of cardiac sur- All the surgical procedures in conventional heart surgery geons. For this procedure, surgeons have been using off-the-shelf require a highly invasive technique, a stemotomy, that tools to perform minimally invasive CABG surgery on the beat- involves opening the patient's chest to gain access to the ing heart.
    [Show full text]
  • The Cardiopulmonary Bypass, Hemolysis, and End Organ Function: an Integration of Political Science, Chemistry, and Zoology
    The Cardiopulmonary Bypass, Hemolysis, and end organ function: an Integration of Political Science, Chemistry, and Zoology By Nathan V. Luce A capstone project submitted to the faculty of Weber State University in fulfillment of the requirements of the degree of Bachelor of Integrated Studies in the Department of Integrated Studies. Ogden, Utah (Date Approved) Approved by: Department Director Dr. Michael Cena Ph.D. Committee Members: Political Science Dr. Gary Johnson Ph.D. Clinical and Clinical Research: Chemistry and Zoology Dr. Peter C. Minneci M.D. Marie Hart Clayton MSN, RN TABLE OF CONTENTS PREFACE......................................................................................................................................... v INTRODUCTION............................................................................................................................... 1 HISTORY AND BASICS: CARDIAC SURGERY AND THE CPB.................................................... 3 Evolution of Cardiac Surgery............................................................................................ 3 Intraoperative........................................................................................................... 5 Effects of Cardiopulmonary Bypass................................................................................. 6 Mechanical............................................................................................................... 6 Physiological: Whole Body Inflammatory Response...............................................
    [Show full text]
  • Structured Review of Post-Cardiotomy Extracorporeal Membrane Oxygenation
    ACCEPTED MANUSCRIPT Structured review of post-cardiotomy extracorporeal membrane oxygenation: part 2 - Pediatric patients Roberto Lorussoa*, MD, PhD, Giuseppe Maria Raffab*, MD, Mariusz Kowalewskic , MD, Khalid Alenizya, MD, Niels Sluijpersa, MD, Maged Makhoula, MD, Daniel Brodied, MD, Mike McMullane, MD, I-Wen Wangf, MD, Paolo Meanig, MD, Graeme MacLarenh, MD, Heidi Daltoni, MD, Ryan Barbaroj, MD, Xaotong Houk, MD, Nicholas Cavarocchil, MD, Yih-Sharng Chenm, MD, PhD, Ravi Thiagarajann, MD, PhD, Peta Alexandern, MBBS, Bahaaldin Alsoufio, MD, PhD, Christian A. Bermudezp, MD, Ashish S. Shahq, MD, Jonathan Haftr, MD, Lilia Oretos, MD, David A. D’Alessandrot, MD, Udo Boekenu, MD, PhD, and Glenn Whitmanv, MD From the aCardio-Thoracic Surgery Dept., Heart & Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands; bDepartment for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS—ISMETT (Istituto Mediterraneo per I Trapianti e Terapie ad alta specializzazione), Palermo, Italy; cDepartment of Cardiac Surgery, Antoni Jurasz Memorial University Hospital, Bydgoszcz, Poland; dDivision of Pulmonary & Critical Care Medicine, Columbia University, New York, NY; eCardiac Surgery Unit, Seattle Children Hospital, Seattle, Washington; fCardiac Transplantation and Mechanical Circulatory Support Unit, Indiana University School of Medicine, Health Methodist Hospital, Indianapolis, Indiana; gCardiology Dept., Heart & Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands;
    [Show full text]
  • Design and Development of a Combined Cardiovascular Assist System for Support in Severe Ventricular Failure
    RICE UNIVERSITY DESIGN AND DEVELOPMENT OF A COMBINED CARDIOVASCULAR ASSIST SYSTEM FOR SUPPORT IN SEVERE VENTRICULAR FAILURE by Robert L. Peterson A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE THESIS DIRECTOR'S SIGNATURE: (MAY 1979) ABSTRACT Title: Design and Development of a Combined Cardiovascular Assist System for Support in Severe Ventricular Failure Author: Robert L. Peterson This thesis work documents the design and testing of a ventricular assist system combining intra-aortic balloon pumping (IABP) with partial veno-arterial bypass (VABP), both pulsatile and nonpulsatile. A series of animal experiments was carried out after verification of the concept on a mock circulation. Although statistical significance was not obtained, the results were encouraging. This system combines the beneficial features of the two devices in a synergistic manner to obtain a system capable of total body support while at the same time improving the viability of the damaged myocardium. IABP, itself incapable of supporting the circulation in severe heart failure, is used to reduce the afterload caused by VABP, which can provide more profound circulatory assistance. Diastolic augmentation by pulsatile VABP enhances that due to IABP, and there is further enhancement of IABP function due to increased mean arterial pressure. A decrease in heart preload pressure was seen which reflected the decreased venous return brought about by bypass. Thus, in spite of increased total body perfusion, cardiac output was diminished. The decrease in cardiac output was sufficient to reduce heart flow work even though there was an increase in afterload pressure. Finally, the state of the animal seemed to be improved by the assist system in that arrhythmia and mortality were decreased during combined assistance.
    [Show full text]
  • Percutaneous Balloon Mitral Valvulotomy with Transesophageal Echocardiographic Monitoring: Experience in Khon Kaen University
    Percutaneous Balloon Mitral Valvulotomy with Transesophageal Echocardiographic Monitoring: Experience in Khon Kaen University SONGSAK KIATCHOOSAKUN, M.D.*, SONGKWAN SILARUKS, M.D.*, PYATAT TATSANAVIVAT,M.D.*, VIRAT KLUNGBOONKRONG, M.D.*, SUDA TANSUPHASA WADIKUL, M.D.** Abstract To study the results and complications of Percutaneous Balloon Mitral Valvulotomy with Transesophageal Echocardiographic monitoring in patients with symptomatic mitral stenosis. From November 1996 to November 1998, PBMV with TEE monitoring was performed in 107 patients with symptomatic mitral stenosis. There were 72 females and 35 males, aged 19 to 65 years (mean 37 .63). The mitral valve was successfully dilated in 104 patients. Immediately after PBMV, there was significant reduction of mean mitral valve gradient (17.89 ± 6.7 mm Hg to 6.21 ± 3.02 mm Hg), mean left atrial pressure (26.67 ± 6.61 mm Hg to 13.97 ± 4.7 mm Hg), mean pulmonary artery pressure (35.21 ± 13.03 mm Hg to 27.71 ± 10.31 mm Hg). Mitral valve area was increased from 0.80 ± 0.24 cm2 to 1.75 ± 0.42 cm2 and cardiac output was increased from 3.84 ± 0.97 Llmin to 4.74 ± 1.09 Llmin. Mitral regurgitation was detected in 20 patients, severe mitral regurgitaion appeared in one patient. None of these patients required emergency surgery. Cardiac tamponade was detected in one case and resolved by pericardiocentesis. TEE was well tolerated and no complications of TEE were detected. PBMV aided by TEE is safe and well tolerated. Key word : Transesophageal Echocardiography, Percutaneous Balloon Mitral Valvulotomy, Khon Kaen University KIATCHOOSAKUN S, SILARUKS S, TATSANAVIVAT P, KLUNGBOONKRONG V, TANSUPHASAWADIKUL S J MED Assoc Thai 2000; 83: 1486-1491 Percutaneous Balloon Mitral Valvulotomy The serious complications of this procedure are (PBMV) is a well established method of treating cardiac perforation during interatrial septal puncture symptomatic mitral valve stenosis patients0-4).
    [Show full text]